SEC Form 3 · accession 0001140361-15-017033
ROCK CREEK PHARMACEUTICALS, INC. · RCPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sunitha Chundru Samuel
Director
Period of report
Apr 20, 2015
Accepted (ET)
Apr 30, 2015 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000776008
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 5,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Purchase Common StockF1 | $3.00 | holding | — | — | — | — | Apr 20, 2025 | Common Stock | 2,000 | — | D |
Explanation of responses
- F1Options to purchase common stock, granted pursuant to the issuer's Third Amended and Restated 2008 Incentive Award Plan, are exercisable as follows: 50% on the first anniversary of the date of grant and 100% on the second anniversary of the date of grant,